Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,947 | 11,638 | 15,921 | 17,682 | 19,690 |
| Receivables | N/A | N/A | N/A | 1,974 | 1,975 |
| TOTAL | $16,584 | $12,326 | $16,779 | $20,198 | $22,756 |
| Non-Current Assets | |||||
| PPE Net | 2,359 | 2,232 | 2,124 | 1,740 | 1,355 |
| Other Non-Current Assets | 1,138 | 1,078 | 989 | 1,010 | 1,031 |
| TOTAL | $3,496 | $3,310 | $3,113 | $2,750 | $2,386 |
| Total Assets | $20,081 | $15,635 | $19,892 | $22,948 | $25,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,709 | 9,939 | 9,240 | 8,622 | 6,502 |
| TOTAL | $10,851 | $10,010 | $9,307 | $8,687 | $6,565 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 965 | 972 | 991 | 1,010 | 1,026 |
| TOTAL | $965 | $972 | $991 | $1,010 | $1,026 |
| Total Liabilities | $11,816 | $10,982 | $10,299 | $9,697 | $7,591 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,578 | 28,834 | 27,877 | 27,722 | 27,508 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -93,776 | -86,190 | -79,567 | -75,025 | -70,213 |
| Other shareholders' equity | -37 | -35 | -85 | -101 | 92 |
| TOTAL | $8,265 | $4,653 | $9,594 | $13,251 | $17,551 |
| Total Liabilities And Equity | $20,081 | $15,635 | $19,892 | $22,948 | $25,142 |